Naturopathic physician scope

AN ACT Relating to naturopathic physician scope of practice; 1
amending RCW 18.36A.020, 18.36A.040, 69.41.030, and 69.50.101; adding 2
new sections to chapter 18.36A RCW; and creating a new section.3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:4
NEW SECTION. Sec. 1. The legislature finds:5
(1) Naturopathic physicians are recognized as primary care 6
providers in both statute and rule, and have served in this role for 7
many years through private health plans, in apple health, and with 8
the Indian health service systems. 9
(2) Washington has a shortage of primary care services that poses 10
a significant risk to public health resulting in increased human 11
suffering and increased costs. The coronavirus pandemic added strain 12
on an already overburdened health care system, further exposing the 13
need to empower primary care providers to practice to the full scope 14
of their training. 15
(3) In some areas, naturopathic physicians are the only available 16
health care providers. As such, they need authority for all 17
appropriate primary care services consistent with their education and 18
patient populations. This act supports better patient care, prevents 19
duplication of services, reduces emergency department visits, and is 20
more cost-effective for patients, health plans, and state agencies.21
H-1219.1
HOUSE BILL 1888
State of Washington 69th Legislature 2025 Regular Session
By Representatives Berg, Walen, Wylie, Doglio, Ryu, Parshley,
Goodman, Santos, Morgan, Duerr, Ramel, Hill, and Macri
Read first time 02/07/25. Referred to Committee on Health Care &
Wellness.
p. 1 HB 1888
(4) Naturopathic medical training emphasizes prevention and 1
comprehensive primary care and includes the same basic and clinical 2
science courses as would be taught in any conventional medical 3
program in addition to behavioral health, counseling, and lifestyle 4
medicine. Many patients seek care with naturopathic physicians in 5
order to stop taking or lower their doses of prescription 6
medications. Most controlled substances cannot be stopped without a 7
careful dosage taper. Enabling naturopathic physicians to practice to 8
the full extent of their training, to include authority to prescribe 9
and deprescribe controlled substances, allows them to play a more 10
significant role in addressing the ongoing opioid and benzodiazepine 11
crises facing our communities. 12
(5) The legislature first granted naturopathic physicians limited 13
prescriptive authority in 1987 and expanded this in 2005 to include 14
all legend drugs and limited controlled substances in Schedules III 15
through V of the uniform controlled substances act. Licensed 16
naturopathic physicians in several states currently have prescriptive 17
authority beyond what those in Washington have. Licensed naturopathic 18
physicians have demonstrated competence and safety in prescribing 19
controlled substances both here and in surrounding states.20
(6) This act recognizes the board of naturopathy and its role in 21
rule making for determination of specific clinical parameters and 22
educational requirements in the same manner as other boards and 23
commissions with primary care authority. 24
Sec. 2. RCW 18.36A.020 and 2021 c 179 s 2 are each amended to 25
read as follows: 26
Unless the context clearly requires otherwise, the definitions in 27
this section apply throughout this chapter. 28
(1) "Board" means the board of naturopathy created in RCW 29
18.36A.150. 30
(2) "Colon hydrotherapist" means a person certified under this 31
chapter to perform colon hydrotherapy pursuant to an affiliation with 32
one or more naturopaths. 33
(3) "Colon hydrotherapy" means the performance of enemas or 34
colonic irrigation. 35
(4) "Common diagnostic procedures" means the use of venipuncture 36
consistent with the practice of naturopathic medicine, commonly used 37
diagnostic modalities consistent with naturopathic practice, health 38
history taking, physical examination, radiography, examination of 39
p. 2 HB 1888
body orifices excluding endoscopy, laboratory medicine, and obtaining 1
samples of human tissues, but excluding incision or excision beyond 2
that which is authorized as a minor office procedure.3
(5) "Department" means the department of health.4
(6) "Educational program" means an accredited program preparing 5
persons for the practice of naturopathic medicine. 6
(7) "Homeopathy" means a system of medicine based on the use of 7
infinitesimal doses of medicines capable of producing symptoms 8
similar to those of the disease treated, as listed in the homeopathic 9
pharmacopeia of the United States. 10
(8) "Hygiene and immunization" means the use of such preventative 11
techniques as personal hygiene, asepsis, public health, and 12
immunizations, to the extent allowed by rule. 13
(9) "Manual manipulation" or "mechanotherapy" means manipulation 14
of a part or the whole of the body by hand or by mechanical means.15
(10) "Minor office procedures" means care and procedures incident 16
thereto of superficial lacerations, lesions, ((and abrasions )) minor 17
injuries, and the removal of foreign bodies located in superficial 18
structures, not to include the eye other than inspection and lavage ; 19
and the use of antiseptics and topical or local anesthetics in 20
connection therewith. "Minor office procedures" also includes 21
((intramuscular, intravenous, subcutaneous, and intradermal )) common 22
diagnostic procedures, physical modalities, injections, and topical 23
applications of substances consistent with the practice of 24
naturopathic medicine and in accordance with rules established by the 25
((secretary)) board. 26
(11) "Naturopath" or "naturopathic physician" means an individual 27
licensed under this chapter. 28
(12) "Naturopathic medicines" means vitamins; minerals; botanical 29
medicines; homeopathic medicines; hormones; and ((those legend drugs 30
and controlled )) other nutrients, compounds, and natural substances 31
consistent with naturopathic medical practice ((in accordance with 32
rules established by the board. Controlled substances are limited to 33
codeine and testosterone products that are contained in Schedules 34
III, IV, and V in chapter 69.50 RCW)). 35
(13) "Nutrition and food science" means the prevention and 36
treatment of disease or other human conditions through the use of 37
foods, water, herbs, roots, bark, or natural food elements.38
(14) "Physical modalities" means use of physical, chemical, 39
electrical, and other modalities ((that do not exceed those used as 40
p. 3 HB 1888
of July 22, 2011, in minor office procedures or common diagnostic 1
procedures)), including but not limited to heat, cold, air, light, 2
water in any of its forms, sound, massage, durable medical equipment, 3
and therapeutic exercise. 4
(15) "Radiography" means ((the ordering, but not the 5
interpretation, of radiographic diagnostic and other imaging studies 6
and)) the taking and interpretation of standard radiographs.7
(16) "Secretary" means the secretary of health or the secretary's 8
designee. 9
(17) "Suggestion" means techniques including but not limited to 10
counseling, biofeedback, and hypnosis. 11
Sec. 3. RCW 18.36A.040 and 2011 c 40 s 2 are each amended to 12
read as follows: 13
Naturopathic medicine is the practice by ((naturopaths)) 14
naturopathic physicians of the art and science of the diagnosis, 15
prevention, and treatment of disorders of the body by stimulation or 16
support, or both, of the natural processes of the human body. A 17
((naturopath)) naturopathic physician is responsible and accountable 18
to the consumer for the quality of naturopathic care rendered.19
The practice of naturopathic medicine includes manual 20
manipulation (mechanotherapy), the prescription, administration, 21
dispensing, and use, except for the treatment of malignancies, of 22
nutrition and food science, physical modalities, minor office 23
procedures, homeopathy, naturopathic medicines, legend and nonlegend 24
drugs and controlled substances contained in Schedules III through V, 25
and stimulant medications contained in Schedule II, of the uniform 26
controlled substances act, chapter 69.50 RCW, hygiene and 27
immunization, contraceptive devices, common diagnostic procedures, 28
and suggestion; however, nothing in this chapter shall prohibit 29
consultation and treatment of a patient in concert with a 30
practitioner licensed under chapter 18.57 or 18.71 RCW. No person 31
licensed under this chapter may employ the term "chiropractic" to 32
describe any services provided by a ((naturopath)) naturopathic 33
physician under this chapter. 34
NEW SECTION. Sec. 4. A new section is added to chapter 18.36A 35
RCW to read as follows: 36
(1) Subject to the requirements of this section, a naturopathic 37
physician may prescribe and administer legend drugs and controlled 38
p. 4 HB 1888
substances contained in Schedules III through V, and stimulant 1
medications in Schedule II, of the uniform controlled substances act, 2
chapter 69.50 RCW, as necessary in the practice of naturopathy.3
(2) Prior to prescribing controlled substances other than 4
testosterone and codeine products, a naturopathic physician must:5
(a) Pass an examination approved by the board in rule assessing 6
competence in pharmaceutical prescribing; and 7
(b) Register with the department to access the prescription 8
monitoring program established in chapter 70.225 RCW.9
(3) By rule, the board shall establish any additional education 10
and training requirements related to prescribing legend drugs and 11
controlled substances. The governor shall make every effort to 12
appoint at least one naturopathic physician with experience 13
prescribing controlled substances to serve on the board. If that is 14
not possible, the board shall consult with a naturopathic physician 15
or other licensed health care professional with this experience to 16
develop any additional education and training requirements related to 17
prescribing legend drugs and controlled substances. A naturopathic 18
physician may prescribe and administer drugs pursuant to subsection 19
(1) of this section only if they satisfy the education and training 20
requirements established in this section and by the board.21
NEW SECTION. Sec. 5. A new section is added to chapter 18.36A 22
RCW to read as follows: 23
A naturopathic physician may sign and attest to any certificates, 24
cards, forms, or other required documentation that a physician may 25
sign, so long as it is within the naturopathic physician's scope of 26
practice. This includes, but is not limited to, disability 27
determinations, physician orders for life-sustaining treatment, 28
hospice orders, student athletic forms, guardianships, powers of 29
attorney, and similar legal documents. 30
Sec. 6. RCW 69.41.030 and 2024 c 102 s 2 are each amended to 31
read as follows: 32
(1) It shall be unlawful for any person to sell or deliver any 33
legend drug, or knowingly possess any legend drug, or knowingly use 34
any legend drug in a public place, except upon the order or 35
prescription of a physician under chapter 18.71 RCW, an osteopathic 36
physician and surgeon under chapter 18.57 RCW, an optometrist 37
licensed under chapter 18.53 RCW who is certified by the optometry 38
p. 5 HB 1888
board under RCW 18.53.010, a dentist under chapter 18.32 RCW, a 1
podiatric physician and surgeon under chapter 18.22 RCW, a 2
naturopathic physician under chapter 18.36A RCW, a licensed midwife 3
to the extent authorized under chapter 18.50 RCW, a veterinarian 4
under chapter 18.92 RCW, a commissioned medical or dental officer in 5
the United States armed forces or public health service in the 6
discharge of his or her official duties, a duly licensed physician or 7
dentist employed by the veterans administration in the discharge of 8
his or her official duties, a registered nurse or advanced practice 9
registered nurse ((practitioner)) under chapter 18.79 RCW when 10
authorized by the board of nursing, a pharmacist licensed under 11
chapter 18.64 RCW to the extent permitted by drug therapy guidelines 12
or protocols established under RCW 18.64.011 and authorized by the 13
commission and approved by a practitioner authorized to prescribe 14
drugs, a physician assistant under chapter 18.71A RCW when authorized 15
by the Washington medical commission, or any of the following 16
professionals in any province of Canada that shares a common border 17
with the state of Washington or in any state of the United States: A 18
physician licensed to practice medicine and surgery or a physician 19
licensed to practice osteopathic medicine and surgery, a naturopathic 20
physician licensed to practice naturopathic medicine, a dentist 21
licensed to practice dentistry, a podiatric physician and surgeon 22
licensed to practice podiatric medicine and surgery, a licensed 23
advanced practice registered nurse ((practitioner)), a licensed 24
physician assistant, or a veterinarian licensed to practice 25
veterinary medicine: PROVIDED, HOWEVER, That the above provisions 26
shall not apply to sale, delivery, or possession by drug wholesalers 27
or drug manufacturers, or their agents or employees, or to any 28
practitioner acting within the scope of his or her license, or to a 29
common or contract carrier or warehouse operator, or any employee 30
thereof, whose possession of any legend drug is in the usual course 31
of business or employment: PROVIDED FURTHER, That nothing in this 32
chapter or chapter 18.64 RCW shall prevent a family planning clinic 33
that is under contract with the health care authority from selling, 34
delivering, possessing, and dispensing commercially prepackaged oral 35
contraceptives prescribed by authorized, licensed health care 36
practitioners: PROVIDED FURTHER, That nothing in this chapter 37
prohibits possession or delivery of legend drugs by an authorized 38
collector or other person participating in the operation of a drug 39
take-back program authorized in chapter 69.48 RCW.40
p. 6 HB 1888
(2)(a) A violation of this section involving the sale, delivery, 1
or possession with intent to sell or deliver is a class B felony 2
punishable according to chapter 9A.20 RCW. 3
(b) A violation of this section involving knowing possession is a 4
misdemeanor. The prosecutor is encouraged to divert such cases for 5
assessment, treatment, or other services. 6
(c) A violation of this section involving knowing use in a public 7
place is a misdemeanor. The prosecutor is encouraged to divert such 8
cases for assessment, treatment, or other services.9
(d) No person may be charged with both knowing possession and 10
knowing use in a public place under this section relating to the same 11
course of conduct. 12
(e) In lieu of jail booking and referral to the prosecutor for a 13
violation of this section involving knowing possession, or knowing 14
use in a public place, law enforcement is encouraged to offer a 15
referral to assessment and services available under RCW 10.31.110 or 16
other program or entity responsible for receiving referrals in lieu 17
of legal system involvement, which may include, but are not limited 18
to, arrest and jail alternative programs established under RCW 19
36.28A.450, law enforcement assisted diversion programs established 20
under RCW 71.24.589, and the recovery navigator program established 21
under RCW 71.24.115. 22
(3) For the purposes of this section, "public place" has the same 23
meaning as defined in RCW 66.04.010, but the exclusions in RCW 24
66.04.011 do not apply. 25
(4) For the purposes of this section, "use any legend drug" means 26
to introduce the drug into the human body by injection, inhalation, 27
ingestion, or any other means. 28
Sec. 7. RCW 69.50.101 and 2024 c 62 s 17 are each amended to 29
read as follows: 30
The definitions in this section apply throughout this chapter 31
unless the context clearly requires otherwise. 32
(1) "Administer" means to apply a controlled substance, whether 33
by injection, inhalation, ingestion, or any other means, directly to 34
the body of a patient or research subject by: 35
(a) a practitioner authorized to prescribe (or, by the 36
practitioner's authorized agent); or 37
(b) the patient or research subject at the direction and in the 38
presence of the practitioner. 39
p. 7 HB 1888
(2) "Agent" means an authorized person who acts on behalf of or 1
at the direction of a manufacturer, distributor, or dispenser. It 2
does not include a common or contract carrier, public 3
warehouseperson, or employee of the carrier or warehouseperson.4
(3) "Board" means the Washington state liquor and cannabis board.5
(4) "Cannabis" means all parts of the plant Cannabis, whether 6
growing or not, with a THC concentration greater than 0.3 percent on 7
a dry weight basis during the growing cycle through harvest and 8
usable cannabis. "Cannabis" does not include hemp or industrial hemp 9
as defined in RCW 15.140.020, or seeds used for licensed hemp 10
production under chapter 15.140 RCW. 11
(5) "Cannabis concentrates" means products consisting wholly or 12
in part of the resin extracted from any part of the plant Cannabis 13
and having a THC concentration greater than ten percent.14
(6) "Cannabis processor" means a person licensed by the board to 15
process cannabis into cannabis concentrates, useable cannabis, and 16
cannabis-infused products, package and label cannabis concentrates, 17
useable cannabis, and cannabis-infused products for sale in retail 18
outlets, and sell cannabis concentrates, useable cannabis, and 19
cannabis-infused products at wholesale to cannabis retailers.20
(7) "Cannabis producer" means a person licensed by the board to 21
produce and sell cannabis at wholesale to cannabis processors and 22
other cannabis producers. 23
(8)(a) "Cannabis products" means useable cannabis, cannabis 24
concentrates, and cannabis-infused products as defined in this 25
section, including any product intended to be consumed or absorbed 26
inside the body by any means including inhalation, ingestion, or 27
insertion, with any detectable amount of THC. 28
(b) "Cannabis products" also means any product containing only 29
THC content. 30
(c) "Cannabis products" does not include cannabis health and 31
beauty aids as defined in RCW 69.50.575 or products approved by the 32
United States food and drug administration. 33
(9) "Cannabis researcher" means a person licensed by the board to 34
produce, process, and possess cannabis for the purposes of conducting 35
research on cannabis and cannabis-derived drug products.36
(10) "Cannabis retailer" means a person licensed by the board to 37
sell cannabis concentrates, useable cannabis, and cannabis-infused 38
products in a retail outlet. 39
p. 8 HB 1888
(11) "Cannabis-infused products" means products that contain 1
cannabis or cannabis extracts, are intended for human use, are 2
derived from cannabis as defined in subsection (4) of this section, 3
and have a THC concentration no greater than ten percent. The term 4
"cannabis-infused products" does not include either useable cannabis 5
or cannabis concentrates. 6
(12) "CBD concentration" has the meaning provided in RCW 7
69.51A.010. 8
(13) "CBD product" means any product containing or consisting of 9
cannabidiol. 10
(14) "Commission" means the pharmacy quality assurance 11
commission. 12
(15) "Controlled substance" means a drug, substance, or immediate 13
precursor included in Schedules I through V as set forth in federal 14
or state laws, or federal or commission rules, but does not include 15
hemp or industrial hemp as defined in RCW 15.140.020.16
(16)(a) "Controlled substance analog" means a substance the 17
chemical structure of which is substantially similar to the chemical 18
structure of a controlled substance in Schedule I or II and:19
(i) that has a stimulant, depressant, or hallucinogenic effect on 20
the central nervous system substantially similar to the stimulant, 21
depressant, or hallucinogenic effect on the central nervous system of 22
a controlled substance included in Schedule I or II; or23
(ii) with respect to a particular individual, that the individual 24
represents or intends to have a stimulant, depressant, or 25
hallucinogenic effect on the central nervous system substantially 26
similar to the stimulant, depressant, or hallucinogenic effect on the 27
central nervous system of a controlled substance included in Schedule 28
I or II. 29
(b) The term does not include: 30
(i) a controlled substance; 31
(ii) a substance for which there is an approved new drug 32
application; 33
(iii) a substance with respect to which an exemption is in effect 34
for investigational use by a particular person under Section 505 of 35
the federal food, drug, and cosmetic act, 21 U.S.C. Sec. 355, or 36
chapter 69.77 RCW to the extent conduct with respect to the substance 37
is pursuant to the exemption; or 38
p. 9 HB 1888
(iv) any substance to the extent not intended for human 1
consumption before an exemption takes effect with respect to the 2
substance. 3
(17) "Deliver" or "delivery" means the actual or constructive 4
transfer from one person to another of a substance, whether or not 5
there is an agency relationship. 6
(18) "Department" means the department of health.7
(19) "Designated provider" has the meaning provided in RCW 8
69.51A.010. 9
(20) "Dispense" means the interpretation of a prescription or 10
order for a controlled substance and, pursuant to that prescription 11
or order, the proper selection, measuring, compounding, labeling, or 12
packaging necessary to prepare that prescription or order for 13
delivery. 14
(21) "Dispenser" means a practitioner who dispenses.15
(22) "Distribute" means to deliver other than by administering or 16
dispensing a controlled substance. 17
(23) "Distributor" means a person who distributes.18
(24) "Drug" means (a) a controlled substance recognized as a drug 19
in the official United States pharmacopoeia/national formulary or the 20
official homeopathic pharmacopoeia of the United States, or any 21
supplement to them; (b) controlled substances intended for use in the 22
diagnosis, cure, mitigation, treatment, or prevention of disease in 23
individuals or animals; (c) controlled substances (other than food) 24
intended to affect the structure or any function of the body of 25
individuals or animals; and (d) controlled substances intended for 26
use as a component of any article specified in (a), (b), or (c) of 27
this subsection. The term does not include devices or their 28
components, parts, or accessories. 29
(25) "Drug enforcement administration" means the drug enforcement 30
administration in the United States Department of Justice, or its 31
successor agency. 32
(26) "Electronic communication of prescription information" means 33
the transmission of a prescription or refill authorization for a drug 34
of a practitioner using computer systems. The term does not include a 35
prescription or refill authorization verbally transmitted by 36
telephone nor a facsimile manually signed by the practitioner.37
(27) "Immature plant or clone" means a plant or clone that has no 38
flowers, is less than twelve inches in height, and is less than 39
twelve inches in diameter. 40
p. 10 HB 1888
(28) "Immediate precursor" means a substance: 1
(a) that the commission has found to be and by rule designates as 2
being the principal compound commonly used, or produced primarily for 3
use, in the manufacture of a controlled substance; 4
(b) that is an immediate chemical intermediary used or likely to 5
be used in the manufacture of a controlled substance; and6
(c) the control of which is necessary to prevent, curtail, or 7
limit the manufacture of the controlled substance. 8
(29) "Isomer" means an optical isomer, but in subsection (33)(e) 9
of this section, RCW 69.50.204(1) (l) and (hh), and 69.50.206(2)(d), 10
the term includes any geometrical isomer; in RCW 69.50.204(1) (h) and 11
(pp)((,)) and 69.50.210(3)(([,])), the term includes any positional 12
isomer; and in RCW 69.50.204(1)(ii), 69.50.204(3), and 69.50.208(1)13
(([,])), the term includes any positional or geometric isomer.14
(30) "Lot" means a definite quantity of cannabis, cannabis 15
concentrates, useable cannabis, or cannabis-infused product 16
identified by a lot number, every portion or package of which is 17
uniform within recognized tolerances for the factors that appear in 18
the labeling. 19
(31) "Lot number" must identify the licensee by business or trade 20
name and Washington state unified business identifier number, and the 21
date of harvest or processing for each lot of cannabis, cannabis 22
concentrates, useable cannabis, or cannabis-infused product.23
(32) "Manufacture" means the production, preparation, 24
propagation, compounding, conversion, or processing of a controlled 25
substance, either directly or indirectly or by extraction from 26
substances of natural origin, or independently by means of chemical 27
synthesis, or by a combination of extraction and chemical synthesis, 28
and includes any packaging or repackaging of the substance or 29
labeling or relabeling of its container. The term does not include 30
the preparation, compounding, packaging, repackaging, labeling, or 31
relabeling of a controlled substance: 32
(a) by a practitioner as an incident to the practitioner's 33
administering or dispensing of a controlled substance in the course 34
of the practitioner's professional practice; or 35
(b) by a practitioner, or by the practitioner's authorized agent 36
under the practitioner's supervision, for the purpose of, or as an 37
incident to, research, teaching, or chemical analysis and not for 38
sale. 39
p. 11 HB 1888
(33) "Narcotic drug" means any of the following, whether produced 1
directly or indirectly by extraction from substances of vegetable 2
origin, or independently by means of chemical synthesis, or by a 3
combination of extraction and chemical synthesis: 4
(a) Opium, opium derivative, and any derivative of opium or opium 5
derivative, including their salts, isomers, and salts of isomers, 6
whenever the existence of the salts, isomers, and salts of isomers is 7
possible within the specific chemical designation. The term does not 8
include the isoquinoline alkaloids of opium. 9
(b) Synthetic opiate and any derivative of synthetic opiate, 10
including their isomers, esters, ethers, salts, and salts of isomers, 11
esters, and ethers, whenever the existence of the isomers, esters, 12
ethers, and salts is possible within the specific chemical 13
designation. 14
(c) Poppy straw and concentrate of poppy straw.15
(d) Coca leaves, except coca leaves and extracts of coca leaves 16
from which cocaine, ecgonine, and derivatives or ecgonine or their 17
salts have been removed. 18
(e) Cocaine, or any salt, isomer, or salt of isomer thereof.19
(f) Cocaine base. 20
(g) Ecgonine, or any derivative, salt, isomer, or salt of isomer 21
thereof. 22
(h) Any compound, mixture, or preparation containing any quantity 23
of any substance referred to in (a) through (g) of this subsection.24
(34) "Opiate" means any substance having an addiction-forming or 25
addiction-sustaining liability similar to morphine or being capable 26
of conversion into a drug having addiction-forming or addiction-27
sustaining liability. The term includes opium, substances derived 28
from opium (opium derivatives), and synthetic opiates. The term does 29
not include, unless specifically designated as controlled under RCW 30
69.50.201, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan 31
and its salts (dextromethorphan). The term includes the racemic and 32
levorotatory forms of dextromethorphan. 33
(35) "Opium poppy" means the plant of the species Papaver 34
somniferum L., except its seeds. 35
(36) "Package" means a container that has a single unit or group 36
of units. 37
(37) "Person" means individual, corporation, business trust, 38
estate, trust, partnership, association, joint venture, government, 39
p. 12 HB 1888
governmental subdivision or agency, or any other legal or commercial 1
entity. 2
(38) "Plant" has the meaning provided in RCW 69.51A.010.3
(39) "Poppy straw" means all parts, except the seeds, of the 4
opium poppy, after mowing. 5
(40) "Practitioner" means: 6
(a) A physician under chapter 18.71 RCW; a physician assistant 7
under chapter 18.71A RCW; an osteopathic physician and surgeon under 8
chapter 18.57 RCW; an optometrist licensed under chapter 18.53 RCW 9
who is certified by the optometry board under RCW 18.53.010 subject 10
to any limitations in RCW 18.53.010; a dentist under chapter 18.32 11
RCW; a podiatric physician and surgeon under chapter 18.22 RCW; a 12
veterinarian under chapter 18.92 RCW; a registered nurse, advanced 13
practice registered nurse ((practitioner)), or licensed practical 14
nurse under chapter 18.79 RCW; a naturopathic physician under chapter 15
18.36A RCW who is licensed under RCW 18.36A.030 subject to any 16
limitations in RCW 18.36A.040 and 18.36A.020; a pharmacist under 17
chapter 18.64 RCW or a scientific investigator under this chapter, 18
licensed, registered or otherwise permitted insofar as is consistent 19
with those licensing laws to distribute, dispense, conduct research 20
with respect to or administer a controlled substance in the course of 21
their professional practice or research in this state.22
(b) A pharmacy, hospital or other institution licensed, 23
registered, or otherwise permitted to distribute, dispense, conduct 24
research with respect to or to administer a controlled substance in 25
the course of professional practice or research in this state.26
(c) A physician licensed to practice medicine and surgery, a 27
physician licensed to practice osteopathic medicine and surgery, a 28
dentist licensed to practice dentistry, a podiatric physician and 29
surgeon licensed to practice podiatric medicine and surgery, a 30
licensed physician assistant or a licensed osteopathic physician 31
assistant specifically approved to prescribe controlled substances by 32
his or her state's medical commission or equivalent and his or her 33
participating physician as defined in RCW 18.71A.010, an advanced 34
practice registered nurse ((practitioner)) licensed to prescribe 35
controlled substances, a naturopathic physician licensed to prescribe 36
controlled substances, or a veterinarian licensed to practice 37
veterinary medicine in any state of the United States.38
(41) "Prescription" means an order for controlled substances 39
issued by a practitioner duly authorized by law or rule in the state 40
p. 13 HB 1888
of Washington to prescribe controlled substances within the scope of 1
his or her professional practice for a legitimate medical purpose.2
(42) "Production" includes the manufacturing, planting, 3
cultivating, growing, or harvesting of a controlled substance.4
(43) "Qualifying patient" has the meaning provided in RCW 5
69.51A.010. 6
(44) "Recognition card" has the meaning provided in RCW 7
69.51A.010. 8
(45) "Retail outlet" means a location licensed by the board for 9
the retail sale of cannabis concentrates, useable cannabis, and 10
cannabis-infused products. 11
(46) "Secretary" means the secretary of health or the secretary's 12
designee. 13
(47) "Social equity plan" means a plan that addresses at least 14
some of the elements outlined in this subsection (47), along with any 15
additional plan components or requirements approved by the board 16
following consultation with the task force created in RCW 69.50.336. 17
The plan may include: 18
(a) A statement that indicates how the cannabis licensee will 19
work to promote social equity goals in their community;20
(b) A description of how the cannabis licensee will meet social 21
equity goals as defined in RCW 69.50.335; 22
(c) The composition of the workforce the licensee has employed or 23
intends to hire; and 24
(d) Business plans involving partnerships or assistance to 25
organizations or residents with connections to populations with a 26
history of high rates of enforcement of cannabis prohibition.27
(48) "State," unless the context otherwise requires, means a 28
state of the United States, the District of Columbia, the 29
Commonwealth of Puerto Rico, or a territory or insular possession 30
subject to the jurisdiction of the United States. 31
(49) "THC concentration" means percent of tetrahydrocannabinol 32
content of any part of the plant Cannabis, or per volume or weight of 33
cannabis product, or the combined percent of tetrahydrocannabinol and 34
tetrahydrocannabinolic acid in any part of the plant Cannabis 35
regardless of moisture content. 36
(50) "Ultimate user" means an individual who lawfully possesses a 37
controlled substance for the individual's own use or for the use of a 38
member of the individual's household or for administering to an 39
p. 14 HB 1888
animal owned by the individual or by a member of the individual's 1
household. 2
(51) "Unit" means an individual consumable item within a package 3
of one or more consumable items in solid, liquid, gas, or any form 4
intended for human consumption. 5
(52) "Useable cannabis" means dried cannabis flowers. The term 6
"useable cannabis" does not include either cannabis-infused products 7
or cannabis concentrates. 8
(53) "Youth access" means the level of interest persons under the 9
age of twenty-one may have in a vapor product, as well as the degree 10
to which the product is available or appealing to such persons, and 11
the likelihood of initiation, use, or addiction by adolescents and 12
young adults. 13
--- END ---
p. 15 HB 1888